Vernalis to cut jobs21st February 2008
Vernalis has unveiled plans to cuts its workforce by just over half after it became the latest casualty in the UK biotechnology sector.
Chief executive Simon Sturge also announced that he is to step down in a restructuring that will see Vernalis offload its US commercial operations along with one of its top selling drugs Apokyn, and cut its workforce from 210 to 90. Mr Sturge will not be replaced and the company will be run by executive chairman Peter Fellner.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Vernalis to cut jobs
Author: Mark Nicholls
Article Id: 5723
Date Added: 21st Feb 2008